Foghorn Therapeutics Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
29.53 |
29.94 |
31.34 |
44.05 |
79.96 |
168.71 |
| Przychód Δ r/r |
0.00% |
1.39% |
4.67% |
40.54% |
81.53% |
111.00% |
| Przychód (min) |
26.00 |
22.30 |
31.34 |
42.33 |
58.31 |
123.02 |
| Przychód (max) |
42.25 |
39.80 |
31.34 |
45.77 |
102.29 |
215.83 |
| EBITDA (średnia) |
-29.53 |
-29.94 |
-31.34 |
-44.05 |
-79.96 |
-168.71 |
| EBIT (średnia) |
-29.53 |
-29.94 |
-31.34 |
-44.05 |
-79.96 |
-168.71 |
| EBIT % |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
| Zysk netto (średni) |
-80.44 |
-72.31 |
-87.47 |
-89.09 |
-32.12 |
27.18 |
| Zysk netto % |
-272.35% |
-241.48% |
-279.08% |
-202.27% |
-40.17% |
16.11% |
| EPS (średnia) |
-1.54 |
-1.32 |
-1.26 |
-1.33 |
-0.58 |
0.49 |
| Liczba analityków (Przychody) |
6 |
6 |
7 |
7 |
4 |
3 |
| Liczba analityków (EPS) |
5 |
6 |
6 |
5 |
2 |
1 |
| symbol |
FHTX |
FHTX |
FHTX |
FHTX |
FHTX |
FHTX |